PRIA Logo™
119-s-2294119th CongressWALLET

Kay Hagan Tick Reauthorization Act

Sponsored By: Senator Collins, Susan M. [R-ME]

Introduced

Summary

Reauthorizes federal programs to fight tick- and other vector-borne diseases. It would extend two Public Health Service Act programs through FY2026–FY2030 while setting new annual funding levels and tightening who is referenced in the statute.

Show full summary
  • National strategy and Regional Centers of Excellence would be reauthorized under Section 317U (42 U.S.C. 247b-23) with an authorized amount of $8 million per year for each of fiscal years 2026 through 2030, down from $10 million for FY2021–FY2025. This affects the federal program that coordinates research and regional response capacity.
  • Enhanced support to assist health departments would be reauthorized under Section 2822(c) (42 U.S.C. 300hh-32(c)) with $19 million per year for each of fiscal years 2026 through 2030, down from $20 million previously. This funds grants or assistance that state and local health departments use to address vector-borne threats.
  • The bill replaces a specific reference to the Tick-Borne Disease Working Group and other named individuals with the broader phrase "appropriate individuals" in the statutory text. This changes who is cited in the law without creating new programs.

*Would reduce the authorized annual funding for these two programs compared with the prior authorization levels.*

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

1 provisions identified: 0 benefits, 1 costs, 0 mixed.

Lower grants for vector-borne disease programs

If enacted, this bill would lower annual authorized grant funding for two federal vector-borne disease programs for fiscal years 2026 through 2030. It would replace a prior $10 million per-year authorization with $8 million per year for the National Strategy and Regional Centers of Excellence in Vector-Borne Disease. It would also replace a prior $20 million per-year authorization with $19 million per year for enhanced support to help state and local health departments. These authorizations would take effect upon enactment and would end on September 30, 2030.

Sponsors & CoSponsors

Sponsor

Collins, Susan M. [R-ME]

ME • R

Cosponsors

  • Sen. Smith, Tina [D-MN]

    MN • D

    Sponsored 7/15/2025

  • Sen. King, Angus S., Jr. [I-ME]

    ME • I

    Sponsored 7/15/2025

  • Sen. Hawley, Josh [R-MO]

    MO • R

    Sponsored 7/22/2025

  • Sen. Klobuchar, Amy [D-MN]

    MN • D

    Sponsored 7/22/2025

  • Sen. Gillibrand, Kirsten E. [D-NY]

    NY • D

    Sponsored 7/22/2025

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation